Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to $965669.3.

  • Avricore Health's Liabilities and Shareholders Equity fell 5643.92% to $965669.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 3427.4%. This contributed to the annual value of $1.7 million for FY2024, which is 1075.77% down from last year.
  • As of Q3 2025, Avricore Health's Liabilities and Shareholders Equity stood at $965669.3, which was down 5643.92% from $1.2 million recorded in Q2 2025.
  • Avricore Health's 5-year Liabilities and Shareholders Equity high stood at $2.2 million for Q3 2024, and its period low was $965669.3 during Q3 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $1.8 million (2021), whereas its average is $1.8 million.
  • Per our database at Business Quant, Avricore Health's Liabilities and Shareholders Equity soared by 64903.74% in 2021 and then crashed by 5643.92% in 2025.
  • Over the past 5 years, Avricore Health's Liabilities and Shareholders Equity (Quarter) stood at $1.8 million in 2021, then grew by 4.57% to $1.9 million in 2022, then dropped by 1.49% to $1.9 million in 2023, then decreased by 11.75% to $1.6 million in 2024, then plummeted by 41.31% to $965669.3 in 2025.
  • Its Liabilities and Shareholders Equity was $965669.3 in Q3 2025, compared to $1.2 million in Q2 2025 and $1.5 million in Q1 2025.